Skip to navigation Skip to main content
preloader
  • Home
  • About Us
  • Technologies & Applications
    • Regenerative Medicine Applications | Amniotic Fluid Stem Cells
    • Regenerative Medicine Applications | Exosomes
    • Aesthetic Medicine Applications | Deer-Derived Exosomes
    • Healthcare & Wellness Series | Deer Velvet Antler Peptide ACT.A
  • New Drug Development
  • i-ExoCraft®
  • News & Updates
    • Video Gallery
    • Press Coverage
      • Drug Development & Regulatory Affairs
      • Technology Platform & R&D
      • International Expansion & Out-Licensing
      • Products & Commercial Partnerships
  • Investor Relations
  • Contact Us
  • English
    • Chinese (Traditional)

Uncategorized

i-ExoCraft® Platform: World’s First AI-Driven Exosome Design & Manufacturing Platform

The world's first AI-driven Exosome Design House platform for integrated exosome design and manufacturing. Tailored for multidimensional scenarios across aesthetics, skincare, and precision medicine, it analyzes miRNA and proteomic profiles for functional prediction, delivering evidence-based, patented, and differentiated products for clients.
Continue reading

International Certification: Industry-Leading Number of Exosome INCI Registrations

Demonstrating international R&D capabilities, we have successfully obtained 6 exosome INCI (International Nomenclature of Cosmetic Ingredients) registrations covering multiple cell sources, including human AFSCs. We provide flexible and diverse ingredient formulation solutions to fully empower the innovative development of premium skincare products.
Continue reading

GTP-Grade Cell banking: Exclusive AFSC Isolation & 20-Year Cryopreservation

In our high-specification GTP laboratory certified by the Taiwan FDA (TFDA), we provide exclusive amniotic fluid stem cell isolation and purification services for expectant mothers, along with up to 20 years of liquid nitrogen cryopreservation, seamlessly connecting to diverse personalized regenerative medicine and product applications.
Continue reading

Amniotic Fluid Stem Cell Exosomes (AFSC-EXO): Rich in Diverse Bioactivity

Accordingtoa 2025 study from the University of Oxford, amniotic fluid exosomes contain a richer and more diverse miRNA profile than umbilical cord stem cell exosomes, demonstrating superior bioactivity and efficacy in regulating tissue regeneration, anti-inflammation, and anti-fibrosis.
Continue reading
  • 1
  • 2

Tel: 02-2697-5599 | Email: service@u-neuron.com | Address: 18F.-5, No. 99, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City, Taiwan

Copyright © 2026 All Rights Reserved.

Tel: 02-2697-5599
Email: service@u-neuron.com
Address: 18F.-5, No. 99, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City, Taiwan

Copyright © 2026 All Rights Reserved.

  • Home
  • About Us
  • Technologies & Applications
    • Regenerative Medicine Applications | Amniotic Fluid Stem Cells
    • Regenerative Medicine Applications | Exosomes
    • Aesthetic Medicine Applications | Deer-Derived Exosomes
    • Healthcare & Wellness Series | Deer Velvet Antler Peptide ACT.A
  • New Drug Development
  • i-ExoCraft®
  • News & Updates
    • Video Gallery
    • Press Coverage
      • Drug Development & Regulatory Affairs
      • Technology Platform & R&D
      • International Expansion & Out-Licensing
      • Products & Commercial Partnerships
  • Investor Relations
  • Contact Us
  • English
    • Chinese (Traditional)
  • 聯繫顧問
  • 索取資料
  • 預約會議
English Chinese (Traditional)
EnglishChinese (Traditional)